Back Thorens, B, Hodson, DJ (2024) Building the glucagon-like peptide-1 receptor brick by brick: Revisiting a 1993 Diabetes Classic by Thorens et al, Diabetes, 73, 1027-31
Disclaimer: This content is for educational purposes only
Paul Geevarghese, COO and Co-Founder of 9amHealth, stated in the news release announcing the partnernship, "We're not only lowering the cost of medications, we're also connecting members to real, human care: specialists in obesity and diabetes, clinical pharmacists, and ongoing nutritional support with registered dietitiansall from the comfort of home." Adding to that thought, Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company, said, "At Cost Plus Drugs, our commitment to transparent drug pricing has always been unwavering, and with clinical leaders in obesity like 9amHealth, we are dedicated to providing affordable and accessible healthcare solutions for patients with cardiometabolic conditions." What We Don't Know
This difference was not explained by smoking, drinking, physical activity level or pre-existing diseases (such as diabetes or heart disease)
Why Its Added: GLP-1 medications can occasionally contribute to vitamin deficiencies with long-term use
The tumor-promoting role of protein homeostasis: Implications for cancer immunotherapy
